Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10137204 Anti-DLL3 antibody drug conjugates for treating cancer

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10137204

Patent Inventor Names

David Liu0

Orit Foord0

Robert A. Stull0

Scott J. Dylla0

Hui Shao0

Laura Saunders0

Michael Torgov0

Date of Patent

November 27, 2018

Patent Application Number

15266894

Date Filed

September 15, 2016

Patent Citations Received

‌

US Patent 12084518 Trispecific binding proteins and methods of use

‌

US Patent 10308721 Anti-DLL3 antibodies and drug conjugates for use in melanoma

‌

US Patent 11976125 B cell maturation antigen binding proteins

Patent Primary Examiner

‌

Christine J. Saoud

Patent abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10137204 Anti-DLL3 antibody drug conjugates for treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API